Skip to content

The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Anxiety for Patients Undergoing Thyroid Surgery

The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Anxiety for Patients Undergoing Thyroid Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067620
Enrollment
Unknown
Registered
2023-01-13
Start date
2023-01-28
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety

Interventions

T group:Transcutaneous Auricular Vagus Nerve Stimulation
S group:sham stimulation

Sponsors

Huai'an First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elected thyroid surgery and general anesthesia with tracheal intubation; 2.Ages between 18 and 65; 3.No serious systemic disease, ASA grade I~II; 4.No contraindication for the use of vagus nerve stimulator; 5.Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients ever experienced taVNS, or with the conchal cavity skin damage; 2.With contraindications such as cardiac pacemaker or automatic implantable cardiac defibrillator, or fear for electrical stimulation; 3.Airway hyperresponsiveness (asthma, COPD, long-term smoking history); 4.Preoperative sinus bradycardia (heart rate less than 50 beats/minute) or sinus node disease, second or third degree atrioventricular block; 5.Mental illness; Or surgical history of severe craniocerebral trauma; 6.Severe hypertension, diabetes, cardiovascular and cerebrovascular diseases, or major surgical history; 7.Have received long-term anesthetic analgesia, sedation or NSAID treatment; 8.With hearing and language communication barriers and cannot communicate effectively with doctors; 9.Cannot understand the informed consent form or refuse to sign it.

Design outcomes

Primary

MeasureTime frame
state-trait anxiety inventory score;

Secondary

MeasureTime frame
Amsterdam preoperative anxiety and information scale score;Athens insomnia scale score;visual analog scale score;vital signs;types and dosage of analgesics;operation time,surgical manner,anesthesia duration and intraoperative volume.;time of first anal exhaust after operation;postoperative hospital stay;

Countries

China

Contacts

Public ContactZheng Ying

Huai'an First People's Hospital

1794994673@qq.com+86 137 7670 9827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026